Anti-Human CD40 Recombinant Antibody(Lucatumumab)
-
Product Number
YR1112
-
Alias
科研级 Lucatumumab ( 卢卡木单抗 ), Anti-CD40 Recombinant Antibody, Research Grade Lucatumumab
-
Specifications
- 1mg
- 5mg
YR1112
科研级 Lucatumumab ( 卢卡木单抗 ), Anti-CD40 Recombinant Antibody, Research Grade Lucatumumab
| Alias | 科研级 Lucatumumab ( 卢卡木单抗 ), Anti-CD40 Recombinant Antibody, Research Grade Lucatumumab |
| Catalog Number | YR1112 |
| Molecular Name | Lucatumumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Lucatumumab (CHIR 12.12 or HCD122) is a human monoclonal antibody against CD40 development of which was discontinued by Novartis in 2013 after it was investigated for the treatment of various types of cancer like multiple myeloma and follicular lymphoma. |
| CAS Number | 903512-50-5 |
| Application | FCM, IP, ELISA, Neut, FuncS, IF, ICC |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CD40[Homo sapiens] |
0